Solid Tumor

Discover sources of resistance to solid tumor therapies that translate to therapeutic insights

IsoPlexis detects the key potent immune cells that drive response across solid tumor indications in oncology, helping you understand the mechanisms behind resistance in oncology research.

Solid Tumor

See What’s Next in Solid Tumor & Oncology

Explore by Solid Tumor Indications

Use cases & research data

Explore by Therapy Types

Explore by Cell Types

Discover. Optimize. Predict.

IsoPlexis is empowering Solid Tumor & Oncology Research across the discover-optimize-predict continuum

Discover Differences

day 0 day 6 day 10

Leverage the IsoPlexis’ heterogeneity index to predict cancer resistance and enable the development of novel combination treatments.

Identify drug-induced resistance in a correlative manner that can be targeted therapeutically.

Follow Our Data

Optimize Bioprocessing

resp. resistant

Optimize targeting in Solid Tumor & Oncology

Leverage the IsoPlexis’ heterogeneity index to predict cancer resistance and enable the development of novel combination treatments.

Follow Our Data

Predict Response

nonresponders and responders

Correlate data with response to predict clinical outcome

Uncover correlations of TIL function in solid tumors, which can be used for targeting.

Follow Our Data

Explore Resources

Identify the Most Potent Cell Subsets in Your Samples

Our award-winning, single-cell system effortlessly delivers the data you need.

See How
IsoLight